Walleye Capital LLC Exelixis, Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 8,500 shares of EXEL stock, worth $282,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,500

Holding current value

$282,965

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $63,354 - $79,626	2,885 New	2,885 $74,000
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $2.62 Million - $3.1 Million	-129,749 Reduced 69.27%	57,549 $1.37 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $2.91 Million - $3.65 Million	-151,348 Reduced 44.69%	187,298 $4.49 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $4.83 Million - $5.76 Million	253,449 Added 297.49%	338,646 $7.4 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $1.55 Million - $1.74 Million	85,197 New	85,197 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $667,670 - $948,278	42,581 Added 36.54%	159,124 $2.5 Million
Q2 2022 Aug 08, 2022	BUY	$17.44 - $23.16 $1.41 Million - $1.87 Million	80,618 Added 224.41%	116,543 $2.43 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $313,794 - $417,717	18,426 Added 105.3%	35,925 $814,000
Q4 2021 Mar 03, 2022	BUY	$15.84 - $21.88 $277,184 - $382,878	17,499 New	17,499 $319,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $216,969 - $281,394	-13,311 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $329,741 - $469,537	-18,370 Reduced 57.98%	13,311 $243,000
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $650,410 - $798,994	31,681 New	31,681 $716,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $200,668 - $257,077	-11,350 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $109,661 - $143,376	-5,793 Reduced 33.79%	11,350 $243,000
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $336,002 - $424,460	17,143 New	17,143 $408,000

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.12 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$976 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$846 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$511 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$381 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account